To overcome difficulties in classification Uniform Multi Drug Therapy (U-MDT) has been recommended. Aim: To evaluate the benefit of adding clofazimine to paucibacillary regimens …

WHO recommended multidrug therapy (MDT) regimens. The Guidelines for the diagnosis, treatment and prevention of leprosy (WHO, 2018), recommends the same 3-drug regimen with …

Although multidrug therapy (MDT) consisting of dapsone, rifampicin, clofazimine, and ofloxacine (Table 1) is the current strategy for leprosy control programs, 3 many drug-resistant cases …

Uniform multidrug therapy (U-MDT) is a single regimen for all cases of leprosy, lasting for six months. It was first discussed as a serious proposition at the WHO Technical Advisory Group …

2015年1月1日 · Treatment of leprosy has undergone considerable changes over decades, from chaulmoogra oil in 1915 to dapsone monotherapy in 1946, then eventually to multidrug …

2022年10月1日 · Standard MDT treatment is given based on the leprosy classification of paucibacillary (PB) and multibacillary (MB). The utilization of the standard MDT regiment has …

2021年1月16日 · 在mdt 化疗药物的规律治疗下，mb 麻风能够产生有效的带菌免疫状态，清除体内的死菌，协助人体杀灭外界入侵的少量活菌，免于再次感染复发，杀灭人体内少量持久菌，免 …

To overcome difficulties in classification Uniform Multi Drug Therapy (U-MDT) has been recommended. AIM : To evaluate the benefit of adding clofazimine to paucibacillary regimens …

For the treatment of leprosy, the WHO recommended multidrug therapy (MDT) in the year 1981 in the field. This has improved the compliance for the entire spectrum of patients as it was …

However, the WHO-recommended MDT regimens have been shown to be robust i.e. even if taken irregularly, they have benefited patients. What should be done if a PB patient, 9 months after …